[LXRX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
25-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -71.75%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 1,204 139 298 23,995 322,073 63,209 90,335 -51.29%
PBT -177,119 -101,944 -87,758 -58,574 124,119 -120,548 -141,711 3.78%
Tax 386 1,184 510 11,610 -6,014 3,508 -12,661 -
NP -177,119 -103,128 -88,268 -70,184 130,133 -120,548 -129,050 5.41%
Tax Rate - - - - 4.85% - - -
Total Cost 178,323 103,267 88,566 94,179 191,940 183,757 219,385 -3.39%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -14,710.88 -74,192.81 -29,620.13 -292.49 40.40 -190.71 -142.86 116.42%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.80 -0.62 -0.61 -0.63 1.23 -1.14 -1.23 -6.91%
EPS Diluted -0.80 -0.62 -0.61 -0.63 1.11 -1.14 -1.23 -6.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.